Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-006154
Filing Date
2016-05-09
Accepted
2016-05-09 09:16:26
Documents
57
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q panther_10q-022916.htm 10-Q 300167
2 CERTICATION panther_10q-ex3101.htm EX-31.1 8095
3 CERTIFICATION panther_10q-ex3102.htm EX-31.2 8148
4 CERTIFICATION panther_10q-ex3201.htm EX-32.1 2993
5 CERTIFICATION panther_10q-ex3202.htm EX-32.2 2835
  Complete submission text file 0001019687-16-006154.txt   2193152

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pbya-20160229.xml EX-101.INS 357164
7 XBRL SCHEMA FILE pbya-20160229.xsd EX-101.SCH 30995
8 XBRL CALCULATION FILE pbya-20160229_cal.xml EX-101.CAL 45724
9 XBRL DEFINITION FILE pbya-20160229_def.xml EX-101.DEF 59830
10 XBRL LABEL FILE pbya-20160229_lab.xml EX-101.LAB 189411
11 XBRL PRESENTATION FILE pbya-20160229_pre.xml EX-101.PRE 151760
Mailing Address 888 PROSPECT STREET LA JOLLA CA 92037
Business Address 888 PROSPECT STREET LA JOLLA CA 92037 (858) 263-2744
PANTHER BIOTECHNOLOGY, INC. (Filer) CIK: 0001530981 (see all company filings)

EIN.: 331221758 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-55074 | Film No.: 161630098
SIC: 8700 Services-Engineering, Accounting, Research, Management